Patents by Inventor Sarah Wyman

Sarah Wyman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230416339
    Abstract: Provided herein are chimeric transmembrane proteins and proteins, nucleic acids encoding these chimeric transmembrane proteins or proteins, and mammalian cells containing these nucleic acids, and methods of making and using these mammalian cells.
    Type: Application
    Filed: June 1, 2023
    Publication date: December 28, 2023
    Inventors: Peter Emtage, Gabrielle Romain, Rosa Vincent, Sarah Wyman
  • Patent number: 11708401
    Abstract: Provided herein are chimeric transmembrane proteins and proteins, nucleic acids encoding these chimeric transmembrane proteins or proteins, and mammalian cells containing these nucleic acids, and methods of making and using these mammalian cells.
    Type: Grant
    Filed: June 21, 2019
    Date of Patent: July 25, 2023
    Assignee: Kite Pharma, Inc.
    Inventors: Peter Emtage, Gabrielle Romain, Rosa Vincent, Sarah Wyman
  • Publication number: 20200397823
    Abstract: Provided herein are engineered receptors involved in cytokine signaling. Also provided herein are engineered receptors for modulating TGF-? signaling, methods of modulating TGF-? signaling and treating cancer using chimeric antigen receptors.
    Type: Application
    Filed: June 19, 2020
    Publication date: December 24, 2020
    Inventors: Sarah WYMAN, Peter EMTAGE, Gabrielle ROMAIN
  • Publication number: 20200002402
    Abstract: Provided herein are chimeric transmembrane proteins and proteins, nucleic acids encoding these chimeric transmembrane proteins or proteins, and mammalian cells containing these nucleic acids, and methods of making and using these mammalian cells.
    Type: Application
    Filed: June 21, 2019
    Publication date: January 2, 2020
    Inventors: Peter Emtage, Gabrielle Romain, Rosa Vincent, Sarah Wyman
  • Publication number: 20190194617
    Abstract: Provided herein are single-chain and multi-chain chimeric antigen receptors, nucleic acids encoding the same, and mammalian cells expressing the same. Also provided are methods of treating a cancer in a subject using a mammalian cell expressing any of these single-chain and multi-chain chimeric antigen receptors.
    Type: Application
    Filed: December 19, 2018
    Publication date: June 27, 2019
    Inventors: Peter Emtage, Sarah Wyman